EKSO Financials
Ekso Bionics Holdings Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$42.05M
EPS
$-5.04
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-11.33M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$26.65M
Total Liabilities
$13.95M
Shareholders Equity
-
Cash & Equivalents
$6.49M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-9.85M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-33.2%
Net Margin
-70.7%
ROE
-85.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is EKSO revenue?
View EKSO's income statement for detailed revenue data.
Is EKSO profitable?
EKSO reported a loss of $11.33M in the most recent quarter. The net profit margin is -70.7%.
What is EKSO market cap?
EKSO has a market capitalization of $42.05M, making it a small-cap stock.
Does EKSO have debt?
View EKSO's balance sheet for debt information.
What is EKSO cash flow?
Cash flow data is available in the full financial statements.